Notably, the ratio demonstrated superior predictive performance for NAFLD compared to either ALT or HDL-C alone, with an AUC of 0.710 (95% CI: 0.684–0.736). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.